Overexpression of the nuclear factor-kappa B (p65) in association with local failure in patients with head and neck carcinoma undergong radiotherapy or chemoradiotherapy

Head and Neck

Volumn 35, Issue 3, 2013, Pages 370-375

  Quintana, Ana ^a   Avilés, Francesc X ^b   Terra, Ximena ^b   Alcolea, Sonia ^c   Camacho, Mercedes ^c   Quer, Miquel ^a   Vila, Luis ^c   León, Xavier ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

Author keywords

head and neck squamous cell carcinoma; nuclear factor kappa B; p65; radiosensitivity; real time polymerase chain reaction

Indexed keywords

CISPLATIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; SYNAPTOTAGMIN I;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; HYPOPHARYNX CANCER; LARYNX CANCER; LOCAL FAILURE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; PRIORITY JOURNAL; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, MESSENGER; SURVIVAL RATE;

EID: 84874116674     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.22979     Document Type: Article

References (15)

1. Kamangar F, Dores GM, Anderson WF,. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-2150.
2. Karin M,. Nuclear factor-κB in cancer development and progression. Nature 2006; 441: 431-436.
3. Sen R, Baltimore D,. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986; 46: 705-716.
4. Karin M, Cao Y, Greten FR, Li ZW,. NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2: 301-310.
5. Allen CT, Ricker JL, Chen Z, van Waes C,. Role of activated nuclear factor-κB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck. Head Neck 2007; 29: 959-971.
6. Nariai Y, Mishima K, Yoshimura Y, Sekine J,. FAP-1 and NF-κB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosis. Int J Oral Maxillofac Surg 2011; 40: 419-426.
7. Zhang PL, Pellitteri PK, Law A, et al. Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis. Mod Pathol 2005; 18: 924-932.
8. Huang C, Huang K, Wang C, et al. Overexpression of mitogen-activated protein kinase 4 and nuclear factor-κB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Oncol Rep 2009; 22: 89-95.
9. Yoshida K, Sasaki R, Nishimura H, et al. Nuclear factor-κB expression as a novel marker of radioresistance in early-stage laryngeal cancer. Head Neck 2010; 32: 646-655.
10. Didelot C, Barberi-Heyob M, Bianchi A, et al. Constitutive NF-κB activity influences basal apoptosis and radiosensitivity of head-and-neck carcinoma cell lines. Int J Radiat Oncol Biol Phys 2001; 51: 1354-1360.
11. Kato T, Duffey Dc, Ondrey FG, et al. Cisplatin and radiation sensitivity in human head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF-κB. Head Neck 2000; 22: 748-759.
12. Kim KM, Zhang Y, Kim BY, et al. The p65 subunit of nuclear factor-κB is a molecular target for radiation sensitization of human squamous carcinoma cells. Mol Cancer Ther 2004; 3: 693-698.
13. Tamatani T, Azuma M, Motegi K, Takamaru N, Kawashima Y, Bando T,. Cepharanthin-enhaced radiosensitivity through the inhibition of radiation-induced nuclear factor-κB activity in human oral squamous cell carcinoma cells. Int J Oncol 2007; 31: 761-768.
14. Yan M, Xu Q, Zhang P, Zhou XJ, Zhang ZY, Chen WT,. Correlation of NF-κB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma. BMC Cancer 2010; 10: 437.
15. Van Waes C, Chang AA, Lebowitz PF, et al. Inhibition of nuclear factor-kappa B and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma. Int J Radiation Oncol Biol Phys 2005; 63: 1400-1412.